Vanguard Personalized Indexing Management LLC Has $1.08 Million Holdings in Masimo Corporation $MASI

Vanguard Personalized Indexing Management LLC increased its position in Masimo Corporation (NASDAQ:MASI) by 12.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,441 shares of the medical equipment provider’s stock after acquiring an additional 726 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Masimo were worth $1,084,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Masimo by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock valued at $1,894,000 after buying an additional 66 shares during the last quarter. Xponance Inc. lifted its holdings in shares of Masimo by 1.1% during the 1st quarter. Xponance Inc. now owns 7,101 shares of the medical equipment provider’s stock worth $1,183,000 after acquiring an additional 76 shares during the period. Deutsche Bank AG increased its stake in Masimo by 1.5% in the first quarter. Deutsche Bank AG now owns 6,309 shares of the medical equipment provider’s stock valued at $1,051,000 after acquiring an additional 92 shares during the period. State of Michigan Retirement System lifted its stake in Masimo by 1.0% during the first quarter. State of Michigan Retirement System now owns 10,596 shares of the medical equipment provider’s stock worth $1,765,000 after purchasing an additional 100 shares during the period. Finally, Louisiana State Employees Retirement System boosted its stake in Masimo by 0.8% in the 1st quarter. Louisiana State Employees Retirement System now owns 12,400 shares of the medical equipment provider’s stock valued at $2,066,000 after buying an additional 100 shares in the last quarter. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Stock Down 0.3%

Shares of MASI stock opened at $146.78 on Friday. Masimo Corporation has a 52-week low of $133.70 and a 52-week high of $194.88. The firm’s 50-day moving average is $145.60 and its 200-day moving average is $154.55. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.61 and a current ratio of 2.14. The stock has a market cap of $7.97 billion, a price-to-earnings ratio of -17.23 and a beta of 1.28.

Masimo (NASDAQ:MASI) last announced its quarterly earnings results on Thursday, June 20th. The medical equipment provider reported $1.42 earnings per share (EPS) for the quarter. The business had revenue of $617.00 million during the quarter. Masimo had a positive return on equity of 26.54% and a negative net margin of 24.85%. Sell-side analysts predict that Masimo Corporation will post 4.1 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have issued reports on MASI. BTIG Research reissued a “buy” rating and set a $198.00 price objective on shares of Masimo in a report on Thursday, September 11th. Zacks Research raised Masimo from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, September 3rd. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Masimo in a report on Wednesday, October 8th. Piper Sandler upped their price objective on shares of Masimo from $200.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, August 6th. Finally, Wall Street Zen raised Masimo from a “hold” rating to a “buy” rating in a research note on Tuesday, October 14th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Masimo has a consensus rating of “Moderate Buy” and a consensus target price of $194.60.

Insider Activity at Masimo

In other Masimo news, Director William R. Jellison purchased 3,000 shares of the stock in a transaction that occurred on Monday, August 11th. The shares were acquired at an average cost of $145.98 per share, with a total value of $437,940.00. Following the completion of the transaction, the director owned 4,790 shares in the company, valued at $699,244.20. The trade was a 167.60% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 9.70% of the company’s stock.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.